Nasal spray for Covid patients rolled out
Summary : FabiSpray will be marketed at a price of Rs 850 per unit. The recommended dosage for treatment of mild Covid-19…
Summary : FabiSpray will be marketed at a price of Rs 850 per unit. The recommended dosage for treatment of mild Covid-19…
Summary : SOLOSEC® demonstrated a 92.2% clinically and statistically significant cure rate for patients with trichomoniasis based on a landmark Phase 3…
Synopsis : Star Therapeutics has exited stealth mode and announced a spin-off company, Electra Therapeutics. Electra received $84 million in Series B…
Summary : The U.S. Food and Drug Administration has accepted Mirati Therapeutics’ New Drug Application (NDA) for its candidate drug for non-small cell lung cancer (NSCLC). The…
Summary : Western Resources Corp. is pleased to announce that it has signed a subscription agreement (the “Subscription Agreement”) today with Vantage…
Summary : -Results from safety lead-in stage of Marker’s Phase 2 AML trial demonstrate that MT-401 was well-tolerated, eliminated measurable residual disease…
Summary : VivoPower International PLC (NASDAQ: VVPR) (“VivoPower,” the “Company”) is pleased to announce that its wholly-owned subsidiary in Australia, Kenshaw Electrical…
Summary : A federal judge on Wednesday dismissed a proposed class action lawsuit by consumers who accused Pfizer Inc of failing to…
Summary : A study in monkeys pitting the current Moderna Inc (MRNA.O) COVID-19 booster against an Omicron-specific booster showed no significant differences…
Summary : Spain’s Rovi (ROVI.MC) has agreed a 10-year extension to its deal with Moderna (MRNA.O) to manufacture future drugs developed with…